Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-26

Clinical Trial Update: Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating oxaliplatin and fluorouracil with radiation therapy in patients with primary esophageal or stomach cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adrucil (5-fluorouracil)
  • Eloxatin (oxaliplatin)

Snippet

Sponsor: Albany Medical College | Conditions: Esophageal Cancer | Phase 1 | Status: COMPLETED